May 14, 2024 | |
The National Stock Exchange of India Limited | The BSE Limited |
Exchange Plaza, Bandra-Kurla Complex, | Phiroze Jeejeebhoy Towers, |
Bandra (E), Mumbai - 400 051. | Dalal Street, Mumbai - 400 001. |
Scrip Code: STAR | Scrip Code: 532531 |
Dear Sirs, |
Re: Announcement of Board Meeting under Regulation 29 of SEBI Listing Regulations
This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, May 22, 2024, inter alia:
- To consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2024; and
- To consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2024.
Further, as per the provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed from April 1, 2024 and shall open after 48 hrs post declaration of financial results by the Company.
This is for your kind information and record purposes.
Thanks & Regards,
For Strides Pharma Science Limited,
Digitally signed by MANJULA R
MANJULA R Date: 2024.05.14 12:17:09 +05'30'
Manjula Ramamurthy
Company Secretary
ICSI Membership No. A30515